We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Indian Court Reluctantly Backs Biosimilars of Roche’s Herceptin
Indian Court Reluctantly Backs Biosimilars of Roche’s Herceptin
Despite grave doubts, an Indian high court judge is allowing two drugmakers to market and produce contested biosimilars of Roche’s breast cancer therapy Herceptin.